X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (547) 547
Publication (43) 43
Conference Proceeding (5) 5
Book Chapter (3) 3
Book Review (3) 3
Book / eBook (2) 2
Patent (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (196) 196
index medicus (123) 123
hematology (120) 120
male (107) 107
middle aged (106) 106
multiple myeloma - drug therapy (105) 105
female (103) 103
multiple myeloma (94) 94
oncology (93) 93
bortezomib (79) 79
adult (78) 78
aged (78) 78
treatment outcome (54) 54
antineoplastic combined chemotherapy protocols - therapeutic use (52) 52
therapy (50) 50
dexamethasone (46) 46
recurrence (45) 45
aged, 80 and over (41) 41
multiple myeloma - therapy (41) 41
antineoplastic agents - therapeutic use (37) 37
multiple myeloma - pathology (37) 37
stem-cell transplantation (34) 34
hematology, oncology and palliative medicine (33) 33
prognosis (32) 32
antineoplastic combined chemotherapy protocols - adverse effects (29) 29
multiple myeloma - mortality (29) 29
survival (26) 26
cancer (25) 25
chemotherapy (25) 25
survival analysis (25) 25
bone marrow transplantation (24) 24
dose-response relationship, drug (24) 24
multiple myeloma - diagnosis (24) 24
thalidomide (24) 24
thalidomide - analogs & derivatives (24) 24
boronic acids - therapeutic use (23) 23
pyrazines - therapeutic use (23) 23
transplantation (23) 23
abridged index medicus (22) 22
combined modality therapy (22) 22
transplantation, autologous (22) 22
lenalidomide (21) 21
dexamethasone - administration & dosage (20) 20
survival rate (20) 20
disease-free survival (19) 19
lenalidomide plus dexamethasone (19) 19
multiple-myeloma (19) 19
thalidomide - administration & dosage (19) 19
drug administration schedule (18) 18
boronic acids - administration & dosage (17) 17
boronic acids - adverse effects (17) 17
drug resistance, neoplasm (17) 17
hematopoietic stem cell transplantation (17) 17
pyrazines - administration & dosage (17) 17
pyrazines - adverse effects (17) 17
antineoplastic agents - adverse effects (16) 16
care and treatment (16) 16
melphalan (16) 16
multiple myeloma - immunology (16) 16
myeloma (16) 16
thalidomide - therapeutic use (16) 16
apoptosis (15) 15
clinical trials as topic (15) 15
disease progression (15) 15
drug therapy (15) 15
follow-up studies (15) 15
remission induction (15) 15
trial (15) 15
adolescent (14) 14
cells (14) 14
clinical trials and observations (14) 14
cyclophosphamide - administration & dosage (14) 14
multiple myeloma - genetics (14) 14
open-label (14) 14
retrospective studies (14) 14
thalidomide - adverse effects (14) 14
antineoplastic combined chemotherapy protocols - administration & dosage (13) 13
article (13) 13
bone marrow (13) 13
bone-marrow (13) 13
carfilzomib (13) 13
combination (13) 13
dexamethasone - therapeutic use (13) 13
phase-2 (13) 13
research (13) 13
analysis (12) 12
medicine, general & internal (12) 12
salvage therapy (12) 12
time factors (12) 12
antineoplastic agents - administration & dosage (11) 11
cyclophosphamide (11) 11
dexamethasone - adverse effects (11) 11
multiple myeloma - complications (11) 11
neoplasm staging (11) 11
patients (11) 11
proteasome inhibitor (11) 11
stem cell transplantation (11) 11
stem cells (11) 11
bone-marrow transplantation (10) 10
clinical trials (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. e328 - e346
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 12, pp. e538 - e548
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2019, Volume 380, Issue 18, pp. 1726 - 1737
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2003, Volume 348, Issue 26, pp. 2609 - 2617
Journal Article
Nature, ISSN 0028-0836, 03/2011, Volume 471, Issue 7339, pp. 467 - 472
Multiple myeloma is an incurable malignancy of plasma cells, and its pathogenesis is poorly understood. Here we report the massively parallel sequencing of 38... 
PATHOGENESIS | B-CELL LYMPHOMA | BLIMP-1 | GENE | MULTIDISCIPLINARY SCIENCES | STRESS-RESPONSE | EXOSOME | CLASSIFICATION | DIFFERENTIATION | HUMAN CANCER | SOMATIC MUTATIONS | Ribonucleases - genetics | Ribonucleases - chemistry | Genomics | Humans | Molecular Sequence Data | NF-kappa B - metabolism | DNA Repair - genetics | Multiple Myeloma - drug therapy | DNA Mutational Analysis | Protein Biosynthesis - genetics | Multiple Myeloma - enzymology | Proto-Oncogene Proteins B-raf - metabolism | Amino Acid Sequence | Oncogenes - genetics | Models, Molecular | Exons - genetics | Signal Transduction - genetics | Multiple Myeloma - metabolism | Mutation - genetics | Open Reading Frames - genetics | Genome, Human - genetics | Homeodomain Proteins - genetics | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | RNA Processing, Post-Transcriptional - genetics | Proto-Oncogene Proteins B-raf - genetics | CpG Islands - genetics | Blood Coagulation - genetics | Protein Conformation | Histones - metabolism | Transcription, Genetic - genetics | Exosome Multienzyme Ribonuclease Complex | Methylation | Homeostasis - genetics | Multiple Myeloma - genetics | Usage | Multiple myeloma | Development and progression | Genetic aspects | Research | Nucleotide sequencing | Methods | Cancer | Proteins | Pathogenesis | Homeostasis | Genetics | Genomes | Mutation | Kinases | Mass spectrometry
Journal Article